Bausch Health Companies Inc (BHC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bausch Health Companies Inc (BHC) has a cash flow conversion efficiency ratio of -0.835x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$670.00 Million ≈ $484.67 Million USD) by net assets (CA$-802.00 Million ≈ $-580.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Bausch Health Companies Inc (BHC) market capitalisation for the company's overall valuation and market capitalisation.
Bausch Health Companies Inc - Cash Flow Conversion Efficiency Trend (1993–2025)
This chart illustrates how Bausch Health Companies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Bausch Health Companies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bausch Health Companies Inc ranked by their cash flow conversion efficiency. Explore Bausch Health Companies Inc cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Transportadora de Gas del Sur SA ADR
NYSE:TGS
|
0.045x |
|
Construcciones y Auxiliar de Ferrocarriles S.A.
MC:CAF
|
0.141x |
|
BIEM.L .FDLKK Garment Co Ltd
SHE:002832
|
0.029x |
|
Henan Yuguang Gold & Lead Co Ltd
SHG:600531
|
-0.135x |
|
IHS HOLDING LTD. DL-3
F:4JB
|
N/A |
|
ARMOUR Residential REIT Inc
NYSE:ARR
|
0.081x |
|
Autohome Inc ADR
F:8AHB
|
N/A |
|
Cadeler As
OL:CADLR
|
0.148x |
Annual Cash Flow Conversion Efficiency for Bausch Health Companies Inc (1993–2025)
The table below shows the annual cash flow conversion efficiency of Bausch Health Companies Inc from 1993 to 2025. View BHC stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$376.31 Million ≈ $272.22 Million |
CA$1.38 Billion ≈ $997.34 Million |
3.664x | +173.87% |
| 2024-12-31 | CA$-322.00 Million ≈ $-232.93 Million |
CA$1.60 Billion ≈ $1.16 Billion |
-4.960x | +60.59% |
| 2023-12-31 | CA$-82.00 Million ≈ $-59.32 Million |
CA$1.03 Billion ≈ $746.53 Million |
-12.585x | -349.48% |
| 2022-12-31 | CA$260.00 Million ≈ $188.08 Million |
CA$-728.00 Million ≈ $-526.62 Million |
-2.800x | +93.32% |
| 2021-12-31 | CA$-34.00 Million ≈ $-24.60 Million |
CA$1.43 Billion ≈ $1.03 Billion |
-41.941x | -2383.93% |
| 2020-12-31 | CA$605.00 Million ≈ $437.65 Million |
CA$1.11 Billion ≈ $803.68 Million |
1.836x | +38.98% |
| 2019-12-31 | CA$1.14 Billion ≈ $821.77 Million |
CA$1.50 Billion ≈ $1.09 Billion |
1.321x | +147.80% |
| 2018-12-31 | CA$2.81 Billion ≈ $2.04 Billion |
CA$1.50 Billion ≈ $1.09 Billion |
0.533x | +38.40% |
| 2017-12-31 | CA$5.94 Billion ≈ $4.30 Billion |
CA$2.29 Billion ≈ $1.66 Billion |
0.385x | -39.86% |
| 2016-12-31 | CA$3.26 Billion ≈ $2.36 Billion |
CA$2.09 Billion ≈ $1.51 Billion |
0.641x | +75.54% |
| 2015-12-31 | CA$6.03 Billion ≈ $4.36 Billion |
CA$2.20 Billion ≈ $1.59 Billion |
0.365x | -13.58% |
| 2014-12-31 | CA$5.43 Billion ≈ $3.93 Billion |
CA$2.29 Billion ≈ $1.66 Billion |
0.422x | +112.08% |
| 2013-12-31 | CA$5.23 Billion ≈ $3.79 Billion |
CA$1.04 Billion ≈ $753.74 Million |
0.199x | +12.73% |
| 2012-12-31 | CA$3.72 Billion ≈ $2.69 Billion |
CA$656.58 Million ≈ $474.96 Million |
0.177x | +4.62% |
| 2011-12-31 | CA$4.01 Billion ≈ $2.90 Billion |
CA$676.47 Million ≈ $489.35 Million |
0.169x | +215.02% |
| 2010-12-31 | CA$4.91 Billion ≈ $3.55 Billion |
CA$263.19 Million ≈ $190.39 Million |
0.054x | -79.89% |
| 2009-12-31 | CA$1.35 Billion ≈ $979.73 Million |
CA$360.90 Million ≈ $261.07 Million |
0.266x | +56.71% |
| 2008-12-31 | CA$1.20 Billion ≈ $869.22 Million |
CA$204.32 Million ≈ $147.81 Million |
0.170x | -35.25% |
| 2007-12-31 | CA$1.30 Billion ≈ $938.82 Million |
CA$340.85 Million ≈ $246.57 Million |
0.263x | -35.35% |
| 2006-12-31 | CA$1.28 Billion ≈ $929.45 Million |
CA$521.93 Million ≈ $377.56 Million |
0.406x | +12.50% |
| 2005-12-31 | CA$1.38 Billion ≈ $997.94 Million |
CA$498.11 Million ≈ $360.32 Million |
0.361x | +77.00% |
| 2004-12-31 | CA$1.36 Billion ≈ $982.59 Million |
CA$277.09 Million ≈ $200.44 Million |
0.204x | -36.22% |
| 2003-12-31 | CA$881.60 Million ≈ $637.73 Million |
CA$281.98 Million ≈ $203.98 Million |
0.320x | -19.04% |
| 2002-12-31 | CA$845.69 Million ≈ $611.76 Million |
CA$334.10 Million ≈ $241.69 Million |
0.395x | +56.58% |
| 2001-12-31 | CA$1.13 Billion ≈ $814.58 Million |
CA$284.12 Million ≈ $205.53 Million |
0.252x | -41.54% |
| 2000-12-31 | CA$237.46 Million ≈ $171.77 Million |
CA$102.49 Million ≈ $74.14 Million |
0.432x | +131.96% |
| 1999-12-31 | CA$435.30 Million ≈ $314.89 Million |
CA$81.00 Million ≈ $58.59 Million |
0.186x | -82.23% |
| 1998-12-31 | CA$51.20 Million ≈ $37.04 Million |
CA$53.60 Million ≈ $38.77 Million |
1.047x | +1738.12% |
| 1997-12-31 | CA$75.50 Million ≈ $54.62 Million |
CA$4.30 Million ≈ $3.11 Million |
0.057x | +137.53% |
| 1996-12-31 | CA$36.90 Million ≈ $26.69 Million |
CA$-5.60 Million ≈ $-4.05 Million |
-0.152x | -107.12% |
| 1995-12-31 | CA$14.60 Million ≈ $10.56 Million |
CA$31.10 Million ≈ $22.50 Million |
2.130x | +530.85% |
| 1994-12-31 | CA$7.70 Million ≈ $5.57 Million |
CA$2.60 Million ≈ $1.88 Million |
0.338x | -58.19% |
| 1993-12-31 | CA$-2.60 Million ≈ $-1.88 Million |
CA$-2.10 Million ≈ $-1.52 Million |
0.808x | -- |
About Bausch Health Companies Inc
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmac… Read more